| 000 | 01158 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516194929.0 | ||
| 264 | 0 | _c20140502 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2013.53.8421 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMertens, Daniel | |
| 245 | 0 | 0 |
_aPrognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches? _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMar 2014 |
||
| 300 |
_a869-72 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntegrin alpha4 _xmetabolism |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xmetabolism |
| 700 | 1 | _aStilgenbauer, Stephan | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 32 _gno. 9 _gp. 869-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2013.53.8421 _zAvailable from publisher's website |
| 999 |
_c23534747 _d23534747 |
||